Donn S M
Holden Neonatal Intensive Care Unit, University of Michigan Medical Center, Ann Arbor 48109-0254.
Arch Dis Child Fetal Neonatal Ed. 1994 Mar;70(2):F81-3. doi: 10.1136/fn.70.2.f81.
The past decade has witnessed technological advancements which are unparalleled in neonatology. ECMO has been demonstrated to be a powerful rescue treatment, but has perhaps been overutilised and is not universally available. Alternative treatments have been shown to be both safe and efficacious in the management of infants with respiratory failure. Direct head to head clinical trials will probably be necessary to establish appropriate criteria and indications for use, given the wide diversity of pathophysiology these unique patients present.
过去十年见证了新生儿学领域前所未有的技术进步。体外膜肺氧合(ECMO)已被证明是一种强大的挽救治疗方法,但可能存在过度使用的情况,且并非普遍可用。在治疗呼吸衰竭婴儿方面,其他治疗方法已被证明既安全又有效。鉴于这些特殊患者所呈现的病理生理学具有广泛多样性,可能需要直接的头对头临床试验来确定合适的使用标准和适应症。